• 제목/요약/키워드: Neonatal encephalopathy

검색결과 35건 처리시간 0.024초

Predictive factors of death in neonates with hypoxic-ischemic encephalopathy receiving selective head cooling

  • Basiri, Behnaz;Sabzehei, Mohammadkazem;Sabahi, Mohammadmahdi
    • Clinical and Experimental Pediatrics
    • /
    • 제64권4호
    • /
    • pp.180-187
    • /
    • 2021
  • Background: Severe perinatal asphyxia results in multiple organ involvement, neonate hospitalization, and eventual death. Purpose: This study aimed to investigate the predictive factors of death in newborns with hypoxic-ischemic encephalopathy (HIE) receiving selective head cooling. Methods: This cross-sectional descriptive-retrospective study was conducted from 2013 to 2018 in Fatemieh Hospital of Hamadan and included 51 newborns who were admitted to the neonatal intensive care unit with a diagnosis of HIE. Selective head cooling for patients with moderate to severe HIE began within 6 hours of birth and continued for 72 hours. The required data for the predictive factors of death were extracted from the patients' medical files, recorded on a premade form, and analyzed using SPSS ver. 16. Results: Of the 51 neonates with moderate to severe HIE who were treated with selective head cooling, 16 (31%) died. There were significant relationships between death and the need for advanced neonatal resuscitation (P=0.002), need for mechanical ventilation (P=0.016), 1-minute Apgar score (P=0.040), and severely abnormal amplitude-integrated electroencephalography (a-EEG) (P=0.047). Multiple regression of variables or data showed that the need for advanced neonatal resuscitation was an independent predictive factor of death (P=0.0075) and severely abnormal a-EEG was an independent predictive factor of asphyxia severity (P=0.0001). Conclusion: All cases of neonatal death in our study were severe HIE (stage 3). Advanced neonatal resuscitation was an independent predictor of death, while a severely abnormal a-EEG was an independent predictor of asphyxia severity in infants with HIE.

신생아 담즙정체증의 원인질환 및 장기추적 예후인자에 관한 고찰 (Evaluation of the Underlying Etiology and Long-Term Prognostic Factors in Neonatal Cholestasis)

  • 김경모;서정기
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제2권1호
    • /
    • pp.46-58
    • /
    • 1999
  • 목 적: 신생아 담즙정체증은 소아과 소화기 영역에서 중요한 질환의 하나임에도 불구하고 원인 질환 및 장기추적 고찰에 대한 국내의 보고가 드문 실정이다. 따라서 저자들은 신생아 담즙정체증의 원인 및 추적조사시의 합병증 등의 임상적 고찰과 함께 예후인자를 분석하여 신생아 담즙정체증 환아의 진료에 도움을 주고자 본 연구를 시행하였다. 방 법: 1981년부터 1992년까지 12년간 신생아 혹은 초기 영아기에 발생한 담즙정체증으로 서울대학교 어린이병원 소아과에 입원하였던 190명을 대상으로 하였다. 담즙정체증의 원인질환, 추적조사시에 관찰된 합병증 및 사인, 특발성신생아간염과 담도폐쇄증의 초기의 임상적 차이점, 예후 및 예후 인자를 분석하였다. 결 과: 1) 담즙정체증의 원인질환은 190명에서 신생아 간염이 101례(53%), 간외담도계 질환이 84례(44%), 간내담도형성부전증이 5례(3%)이었다. 신생아간염은 특발성신생아간염이 77례(41%), 감염성 신생아 간염이 24례(12%)이었고, 간외담도질환은 담도폐쇄증이 79례(41%), 총수담관낭이 5례(3%)이었다. 2) 추적조사시에 관찰된 주요한 임상적 문제점은 지속적인 고열, 위장관출혈, 간성혼수, 복수 등이었다. 3) 담도폐쇄증 환아에서 지속적인 고열의 원인은 상행성담관염, 혹은 line-related sepsis가 58%이었고, 폐렴이 15%, 요로감염이 8%, 상기도 감염이 7%이었다. 4) 상행성담관염 혹은 line related sepsis의 원인균은 Escherichia coli가 28%로 가장 빈도가 많았고, Coagulase negative staphylococcus가 14%, Streptococcus pneumoniae, Klebsiela pneumoniae가 각각 10%, Enterococcus가 6%, Candida albicans가 4%이었다. 5) 주요한 사인은 간성혼수와 위장관출혈이었다. 6) 특발성신생아간염은 71%, 감염성 신생아간염은 75%의 환아에서 회복되었으며, 대부분 생후 12개월 이내, 주로 6개월 이내에 회복되었다. 미숙아, 초기의 간종대가 작은 경우, 초기 알부민치 높은 경우, 콜레스테롤치, ${\gamma}$-GT치, 빌리루빈치 및 AST치가 낮은 경우에서 예후가 양호하였다. 7) 담도폐쇄증 환아의 Kasai수술후의 5년 생존율은 40%이었고 사망의 대부분은 12개월 이내에 관찰되었다. 가장 중요한 예후인자는 수술시기이었고 수술시기가 12주 이전인 49%가 양호한 예후를 보인 반면에, 12주 이후인 경우는 12%이었다. 8) 담즙정체증의 초기 임상소견중 가장 중요한 예후인자는 원인질환이었다. 9) 특발성신생아간염과 담도폐쇄증 사이에서 차이를 보인 임상소견은 성별, 제태연령, 콜레스테롤 치 및 ${\gamma}$-GT치 이었다. 특발성신생아간염은 남아, 미숙아에서 호발하였고, 낮은 콜레스테롤치 및 ${\gamma}$-GT치를 보였다. 결 론: 우리나라에서 신생아 담즙정체증의 흔한 원인으로는 담도폐쇄증과 특발성신생아간염의 빈도가 가장 높았고, 이외에 감염성 신생아 간염, 총수담관낭, Alagille 증후군 등이었으며, 유전성, 대사성질환은 관찰되지 않았다. 신생아 담즙정체증에서 원인질환은 예후를 결정하는 가장 중요한 요인으로 원인질환에 대한 적절한 진단이 요구되며, 또한 상행성 담관염, 폐렴, 패혈증 등의 감염문제, 간성혼수, 위장관 출혈 등은 장기 추적시의 자주 발생하는 심각한 임상적 문제점으로서 이에 대한 적절한 치료대책이 요구된다고 하겠다.

  • PDF

Neonatal Seizures with Diffuse Cerebral White Matter Lesions on Magnetic Resonance Imaging Associated with Rotavirus Infection: A Report of Three Cases

  • Choi, Min Seon;Park, Sang Kee;Lee, Jae Hee
    • Neonatal Medicine
    • /
    • 제25권2호
    • /
    • pp.85-89
    • /
    • 2018
  • Rotavirus is the major cause of gastroenteritis in children under the age of 5. Rotavirus infection may lead to several neurological complications as meningitis, encephalitis, convulsion, encephalopathy, hemorrhagic shock, central pontine myelinolysis, Guillain-Barre syndrome, and Reye's syndrome. Further, some reports have described diffuse cerebral white matter lesions on diffusion-weighted magnetic resonance imaging (MRI) in neonates with rotavirus induced seizures. Here, we report on three neonates with rotavirus induced seizures with cerebral white matter abnormalities on MRI.

신생아중환자의 약동학적 다양성에 영향을 미치는 요인 (Contributing Factors on Pharmacokinetic Variability in Critically Ill Neonates)

  • 안숙희
    • 한국임상약학회지
    • /
    • 제27권2호
    • /
    • pp.63-68
    • /
    • 2017
  • Neonates have large inter-individual variability in pharmacokinetic parameters of many drugs due to developmental differences. The aim of this study was to investigate the factors affecting the pharmacokinetic parameters of drugs, which are commonly used in critically ill neonates. Factors that reflect physiologic maturation such as gestational age, postnatal age, postconceptional age, birth weight, and current body weight were correlated with pharmacokinetic parameters in neonates, especially preterm infants. Comorbidity characteristics affecting pharmacokinetics in critically ill neonates were perinatal asphyxia, hypoxic ischemic encephalopathy, patent ductus arteriosus (PDA), and renal dysfunction. Administration of indomethacin or ibuprofen in neonates with PDA was associated with the reduced clearance of renally excreted drugs such as vancomycin and amikacin. Therapeutic hypothermia and extracoporeal membrane oxygenation were influencing factors on pharmacokinetic parameters in critically ill neonates. Dosing adjustment and careful monitoring according to the factors affecting pharmacokinetic variability is required for safe and effective pharmacotherapy in neonatal intensive care unit.

X-linked recessive myotubular myopathy with MTM1 mutations

  • Han, Young-Mi;Kwon, Kyoung-Ah;Lee, Yun-Jin;Nam, Sang-Ook;Park, Kyung-Hee;Byun, Shin-Yun;Kim, Gu-Hwan;Yoo, Han-Wook
    • Clinical and Experimental Pediatrics
    • /
    • 제56권3호
    • /
    • pp.139-142
    • /
    • 2013
  • X-linked recessive myotubular myopathy (XLMTM) is a severe congenital muscle disorder caused by mutations in the MTM1 gene and characterized by severe hypotonia and generalized muscle weakness in affected males. It is generally a fatal disorder during the neonatal period and early infancy. The diagnosis is based on typical histopathological findings on muscle biopsy, combined with suggestive clinical features. We experienced a case of a newborn who required intubation and ventilator care because of profound hypotonia and respiratory difficulty. The preliminary diagnosis at the time of request for retrieval was hypoxic ischemic encephalopathy, but the infant was clinically reevaluated for generalized weakness and muscle atrophy. Muscle biopsies showed variability in fiber size and centrally located nuclei in nearly all the fibers. We detected an MTM1 gene mutation of c.1261-1C>A in the intron 10 region, and diagnosed the neonate with myotubular myopathy. The same mutation was detected in his mother.

Thiamine Deficiency in a Child with Short Bowel Syndrome and Review

  • Roilides, Ioannis;Vasilaki, Konstantina;Xinias, Ioannis;Iosifidis, Elias;Antachopoulos, Charalampos;Roilides, Emmanuel
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제22권5호
    • /
    • pp.493-499
    • /
    • 2019
  • Thiamine (vitamin $B_1$) is a water-soluble vitamin that is not endogenously synthesized in humans. It is absorbed by the small intestine, where it is activated. Its active form acts as a coenzyme in many energy pathways. We report a rare case of thiamine deficiency in a 3.5-year old boy with short bowel syndrome secondary to extensive bowel resection due to necrotizing enterocolitis during his neonatal age. The patient was parenteral nutrition-dependent since birth and had suffered from recurrent central catheter-related bloodstream infections. He developed confusion with disorientation and unsteady gait as well as profound strabismus due to bilateral paresis of the abductor muscle. Based on these and a very low thiamine level he was diagnosed and treated for Wernicke encephalopathy due to incomplete thiamine acquisition despite adequate administration. He fully recovered after thiamine administration. After 1999 eight more cases have been reported in the PubMed mostly of iatrogenic origin.

Serum Liver Enzyme Pattern in Birth Asphyxia Associated Liver Injury

  • Chhavi, Nanda;Zutshi, Kiran;Singh, Niranjan Kumar;Awasthi, Ashish;Goel, Amit
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제17권3호
    • /
    • pp.162-169
    • /
    • 2014
  • Purpose: To study temporal pattern of serum liver enzymes levels in newborns with hepatic injury associated with birth asphyxia (BA). Methods: Singleton term newborns with BA and ${\leq}72$ hours of age admitted to neonatal intensive care unit were prospectively enrolled. Term newborns with physiological jaundice and without BA were studied as controls. Serum liver enzymes were measured at <24 hours, 24-72 hours, and at 6-12 days of age for cases and at 1-6 days of age for controls. BA was defined by 1 minute Apgar score <7 or delayed or absent cry with hypoxic ischemic encephalopathy. BA-associated liver injury was defined as serum alanine aminotransferase (ALT) elevation beyond +2 standard deviation (ALT > +2 SD) above the mean of control subjects at any of the three time points. Results: Sixty controls and 62 cases were enrolled. Thirty-five cases (56%) developed BA-associated liver injury (ALT>81 IU/L). They had higher serum levels of ALT, aspartate aminotransferase, lactate dehydrogenase than the control infants, with peak at 24-72 hours. In controls, serum liver enzyme levels were significantly higher in appropriate-for-date (AFD) babies than small-for-date (SFD) babies. Serum enzyme pattern and extent of elevation were comparable between SFD and AFD babies. Degree of serum liver enzyme elevation had no relationship with severity of hypoxic encephalopathy. Conclusion: Serum liver enzyme elevation is common in BA; it peaks at 24-72 hours followed by a sharp decline by 6-12 days of age. Pattern and extent of enzyme elevation are comparable between SFD and AFD babies.

동종 접합자 CPS1 돌연 변이를 동반한 신생아 발병형 Carbamoyl Phosphate Synthetase 1 결핍증의 치명적 사례 (A Fatal Case of Neonatal Onset Carbamoyl Phosphate Synthetase I Deficiency with Homozygous CPS1 Mutation)

  • 윤정하;신승한;고정민;김이경;김한석
    • 대한유전성대사질환학회지
    • /
    • 제18권1호
    • /
    • pp.18-22
    • /
    • 2018
  • Carbamoyl phosphate synthetase I (CPS1) 결핍은 상염색체 열성 유전을 하는 드문 요소회로 대사 이상 질환으로, 요소회로의 첫번째 단계 효소인 CPS1 결핍에 의해 고암모니아혈증이 발생하여 신경학적 이상을 초래하게 되는 질환이다. CPS1 결핍은 신생아기부터 성인까지 여러 시기에 발현될 수 있으나, 주로 신생아기에 증상이 발현하고, 신생아기에 증상이 발생할 경우 치명적인 고암모니아혈증이 발생하여 예후가 불량하여 사망에 이를 수 있다. 본 증례는 고암모니아혈증이 발견되어 투석 및 집중 치료하였음에도 심한 뇌손상이 빠르게 진행되어 사망한 신생아로, CPS1 유전자의 동종 접합자 변이를 확인하여 확진 되었으며 이후 시행한 가족 검사에서 부모와 생존한 자매가 모두 이종 접합자 보인자로 확인되어 보고하는 바이다.

  • PDF

신생아 일과성 고암모니아혈증 1례 (A Case with Transient Hyperammonemia of Newborn)

  • 이희경;이범희;진혜영;김구환;최진호;유한욱
    • Journal of Genetic Medicine
    • /
    • 제7권1호
    • /
    • pp.87-90
    • /
    • 2010
  • 신생아 시기의 고암모니아혈증은 고암모니아성 뇌병증에 의하여 심각한 뇌기능의 장애를 일으킬 수 있다. 이 중 신생아 일과성 고암모니아혈증 (transient hyperammonemia of newborn, THAN)은 신생아 시기에만 일시적으로 고암모니아 혈증을 보이고, 신생아시기에 적절한 진단과 치료를 통해 양호한 예후를 보이는 질환이다. 그러나 일부에서는 고도의 고암모니아 혈증을 보여 이에 대한 응급치료를 요하기도 한다. 본 증례 보고에서는 신생아 시기에 고암모니아혈증이 발견되어, 신대치요법과 약물치료 후호 전된 1례를 기술하고자 한다. 환아는 이후 생후9개월까지 정상 식이와 약물치료 없이 정상발달을 보이며, 고암모니아혈증의 재발이 없었다.

Effects of carnosine and hypothermia combination therapy on hypoxic-ischemic brain injury in neonatal rats

  • Byun, Jun Chul;Lee, Seong Ryong;Kim, Chun Soo
    • Clinical and Experimental Pediatrics
    • /
    • 제64권8호
    • /
    • pp.422-429
    • /
    • 2021
  • Background: Carnosine has antioxidative and neuroprotective properties against hypoxic-ischemic (HI) brain injury. Hypothermia is used as a therapeutic tool for HI encephalopathy in newborn infants with perinatal asphyxia. However, the combined effects of these therapies are unknown. Purpose: Here we investigated the effects of combined carnosine and hypothermia therapy on HI brain injury in neonatal rats. Methods: Postnatal day 7 (P7) rats were subjected to HI brain injury and randomly assigned to 4 groups: vehicle; carnosine alone; vehicle and hypothermia; and carnosine and hypothermia. Carnosine (250 mg/kg) was intraperitoneally administered at 3 points: immediately following HI injury, 24 hours later, and 48 hours later. Hypothermia was performed by placing the rats in a chamber maintained at 27℃ for 3 hours to induce whole-body cooling. Sham-treated rats were also included as a normal control. The rats were euthanized for experiments at P10, P14, and P35. Histological and morphological analyses, in situ zymography, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assays, and immunofluorescence studies were conducted to investigate the neuroprotective effects of the various interventional treatments. Results: Vehicle-treated P10 rats with HI injury showed an increased infarct volume compared to sham-treated rats during the triphenyltetrazolium chloride staining study. Hematoxylin and eosin staining revealed that vehicle-treated P35 rats with HI injury had decreased brain volume in the affected hemisphere. Compared to the vehicle group, carnosine and hypothermia alone did not result in any protective effects against HI brain injury. However, a combination of carnosine and hypothermia effectively reduced the extent of brain damage. The results of in situ zymography, TUNEL assays, and immunofluorescence studies showed that neuroprotective effects were achieved with combination therapy only. Conclusion: Carnosine and hypothermia may have synergistic neuroprotective effects against brain damage following HI injury.